Association study between kynurenine 3-monooxygenase gene and schizophrenia in the Japanese population

N. Aoyama, N. Takahashi, S. Saito, N. Maeno, R. Ishihara, X. Ji, H. Miura, M. Ikeda, T. Suzuki, T. Kitajima, Y. Yamanouchi, Y. Kinoshita, K. Yoshida, N. Iwata, T. Inada, N. Ozaki

Research output: Contribution to journalArticlepeer-review

41 Citations (Scopus)


Several lines of evidence suggest that metabolic changes in the kynurenic acid (KYNA) pathway are related to the etiology of schizophrenia. The inhibitor of kynurenine 3-monooxygenase (KMO) is known to increase KYNA levels, and the KMO gene is located in the chromosome region associated with schizophrenia, 1q42-q44. Single-marker and haplotype analyses for 6-tag single nucleotide polymorphisms (SNPs) of KMO were performed (cases = 465, controls = 440). Significant association of rs2275163 with schizophrenia was observed by single-marker comparisons (P = 0.032) and haplotype analysis including this SNP (P = 0.0049). Significant association of rs2275163 and haplotype was not replicated using a second, independent set of samples (cases = 480, controls = 448) (P = 0.706 and P = 0.689, respectively). These results suggest that the KMO is unlikely to be related to the development of schizophrenia in Japanese.

Original languageEnglish
Pages (from-to)364-368
Number of pages5
JournalGenes, Brain and Behavior
Issue number4
Publication statusPublished - 06-2006

All Science Journal Classification (ASJC) codes

  • Genetics
  • Neurology
  • Behavioral Neuroscience


Dive into the research topics of 'Association study between kynurenine 3-monooxygenase gene and schizophrenia in the Japanese population'. Together they form a unique fingerprint.

Cite this